Volunteer Assignments and Opportunities: Difference between revisions
Snehal.Patel (talk | contribs) No edit summary |
No edit summary |
||
| Line 227: | Line 227: | ||
|- | |- | ||
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident | |'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident | ||
|Jennelle Hodge (JH) | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou||JH | |'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH | | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang||JH | | Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang||JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori||JH | | Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori||JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang||JH | | Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang||JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou||JH | | Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+Path Resident||JH | | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+Path Resident||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 268: | Line 268: | ||
|- | |- | ||
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident | |'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident | ||
|JH | |JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH | | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH | | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty||JH | | Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH | | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH | | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH | | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Need permission for figure? Update WHO? | |Need permission for figure? Update WHO? | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH | | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy via Greg Conboy (Monash Health)||JH | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy via Greg Conboy (Monash Health)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH | | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Add WHO reference | |Add WHO reference | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident (Iris Martin)||JH | | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident (Iris Martin)||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH | |Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH | |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Check reference format | |Check reference format | ||
|- | |- | ||
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH | |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH | | Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge||JH | | Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge||JH | | Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH | | Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH | | Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Pure Erythroid Leukemia||Disease||Ash Yenamandra||JH | | Pure Erythroid Leukemia||Disease||Ash Yenamandra||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH | | Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH | | Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH | | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH | |Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp||JH | |'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Need permission for figure? | |Need permission for figure? | ||
|- | |- | ||
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH | | Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley||JH | | Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH | |'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Acute Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH | | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Check reference format | |Check reference format | ||
|- | |- | ||
| Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH | | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH | | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
|Check reference format | |Check reference format | ||
|- | |- | ||
| Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH | | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
|- | |- | ||
| ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH | | ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH / MS | ||
|?? | |?? | ||
| | | | ||
| | | | ||
|- | |- | ||
| ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH | | ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH / MS | ||
|?? | |?? | ||
| | | | ||
| Line 456: | Line 456: | ||
|Disease | |Disease | ||
|Kay Weng Choy via Greg Conboy (Monash Health) | |Kay Weng Choy via Greg Conboy (Monash Health) | ||
|JH | |JH / MS | ||
|Complete | |Complete | ||
| | | | ||
| Line 464: | Line 464: | ||
|Disease | |Disease | ||
|Daynna Wolff+Path Resident | |Daynna Wolff+Path Resident | ||
|JH | |JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||
| Line 472: | Line 472: | ||
|Disease | |Disease | ||
|Daynna Wolff+Path Resident | |Daynna Wolff+Path Resident | ||
|JH | |JH / MS | ||
|PENDING | |PENDING | ||
| | | | ||